States should form committee to negotiate Covid vaccine price: Chidambaram

Former Finance Minister P. Chidambaram on Friday termed the vaccine policy regressive and asked the states to form committees to negotiate price of the vaccines

P Chidambaram
Congress MP P Chidambaram
IANS New Delhi
2 min read Last Updated : Apr 23 2021 | 9:56 AM IST

Former Finance Minister P. Chidambaram on Friday termed the vaccine policy regressive and asked the states to form committees to negotiate price of the vaccines.

"The central government's decision to allow multiple prices for vaccines is discriminatory and regressive. States must unanimously reject the decision," Chidambaram said.

He suggested that the best way forward is for the State governments to jointly form a Price Negotiation Committee and offer to negotiate a uniform price with the two vaccine manufacturers.

"The joint purchasing power of the State governments will force the manufacturers to agree to a uniform price. States must take the initiative. The central government has abdicated its responsibility and surrendered to corporate profiteering."

On Thursday Congress Interim President Sonia Gandhi wrote to Prime Minister Narendra Modi, alleging that the government has not learnt any lesson from the past and its vaccine policy is arbitrary and discriminatory.

In her letter to the Prime Minister, Sonia Gandhi said, "It's surprising that despite the harsh lessons of last year and pain inflicted to our citizens, the government continues to follow an arbitrary and discriminatory policy which promises to exacerbate existing challenges."

The Congress President said that the policy implies that the government has "abdicated" its responsibility for free vaccination to all.

She asked why the government is allowing profiteering by the companies manufacturing the vaccine in the country.

The Congress demanded that there should be free vaccination for all regardless of the economic condition and the policy should be reversed as there should be uniform pricing of the vaccine.

--IANS

miz/skp/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineP Chidambaram

First Published: Apr 23 2021 | 9:44 AM IST

Next Story